Approvals/TGA/APO-IRBESARTAN HCTZ 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack

Approved

STANDARD

APO-IRBESARTAN HCTZ 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8ddd89e37e84a05e
Product Name: APO-IRBESARTAN HCTZ 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack
Artg Id: 213305
Artg Name: APO-IRBESARTAN HCTZ 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2013-09-26
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01989-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-01988-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

8ddd89e37e84a05e

Type

Standard